Synthesis, structure-activity relationship, and pharmacological profile of analogs of the ASIC-3 inhibitor A-317567. (1/10)

Acid sensing ion channel 1 in lateral hypothalamus contributes to breathing control. (2/10)

The pharmacology and therapeutic potential of small molecule inhibitors of acid-sensing ion channels in stroke intervention. (3/10)

Cyclisation increases the stability of the sea anemone peptide APETx2 but decreases its activity at acid-sensing ion channel 3. (4/10)

Functional expression in Escherichia coli of the disulfide-rich sea anemone peptide APETx2, a potent blocker of acid-sensing ion channel 3. (5/10)

Acid-sensing ion channels contribute to chemosensitivity of breathing-related neurons of the nucleus of the solitary tract. (6/10)

u-PA inhibitor amiloride suppresses peritoneal metastasis in gastric cancer. (7/10)

Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride. (8/10)

• 1
• 2